This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

A surprising new study suggests that COVID-19 may not have originated from bats or pangolins, but rather from a rare fusion ...

BioViva’s journey in gene therapy began with its use of an adeno-associated virus (AAV) vector. The company’s lead gene therapy, BV-702, is AAV-based and is in preclinical development for ...

Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

Vaccinia virus (VACV) confers cross-protective immunity against variola virus, the causative agent of smallpox, and has therefore been extensively exploited as a preventive vaccine. Despite the global ...

BEIJING, Feb. 9 (Xinhua) -- Chinese scientists have developed a gene-editing technique to reduce corn plant height, enabling the creation of compact, high-density varieties resistant to lodging, ...